Tags

Type your tag names separated by a space and hit enter

Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending The Amsterdam STI Clinic Between 2005 and 2016.
Sex Transm Dis. 2018 08; 45(8):534-541.ST

Abstract

BACKGROUND

Victims could become infected with sexually transmitted infections (STIs) during a sexual assault. Several guidelines recommend presumptive antimicrobial therapy for sexual assault victims (SAVs). We assessed the STI positivity rate and treatment uptake of female and male SAVs at the Amsterdam STI clinic.

METHODS

Sexual assault victims answered assault-related questions and were tested for bacterial STI (chlamydia, gonorrhea, and syphilis), hepatitis B, and HIV during their initial visits. Sexual assault victim characteristics were compared with non-SAV clients. Backward multivariable logistic regression analysis was conducted to assess whether being an SAV was associated with a bacterial STI. The proportion of those returning for treatment was calculated.

RESULTS

From January 2005 to September 2016, 1066 (0.6%) of 168,915 and 135 (0.07%) of 196,184 consultations involved female and male SAVs, respectively. Among female SAVs, the STI positivity rate was 11.2% versus 11.6% among non-SAVs (P = 0.65). Among male SAVs, the STI positivity rate was 12.6% versus 17.7% among non-SAVs (P = 0.12). In multivariable analysis, female SAVs did not have increased odds for an STI (odds ratio 0.94; 95% confidence interval, 0.77-1.13), and male SAVs had significantly lower odds for an STI (odds ratio, 0.60; 95% confidence interval, 0.36-0.98). Of SAVs requiring treatment, 89.0% (female) and 92.0% (male) returned.

CONCLUSIONS

The STI positivity rate among female SAVs was comparable with female non-SAVs, but male SAVs had lower odds for having a bacterial STI than did male non-SAVs, when adjusting for confounders. The return rate of SAV for treatment was high and therefore does not support the recommendations for presumptive therapy.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

29465647

Citation

van Rooijen, Martijn S., et al. "Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending the Amsterdam STI Clinic Between 2005 and 2016." Sexually Transmitted Diseases, vol. 45, no. 8, 2018, pp. 534-541.
van Rooijen MS, Schim van der Loeff MF, van Kempen L, et al. Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending The Amsterdam STI Clinic Between 2005 and 2016. Sex Transm Dis. 2018;45(8):534-541.
van Rooijen, M. S., Schim van der Loeff, M. F., van Kempen, L., & de Vries, H. J. C. (2018). Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending The Amsterdam STI Clinic Between 2005 and 2016. Sexually Transmitted Diseases, 45(8), 534-541. https://doi.org/10.1097/OLQ.0000000000000794
van Rooijen MS, et al. Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending the Amsterdam STI Clinic Between 2005 and 2016. Sex Transm Dis. 2018;45(8):534-541. PubMed PMID: 29465647.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending The Amsterdam STI Clinic Between 2005 and 2016. AU - van Rooijen,Martijn S, AU - Schim van der Loeff,Maarten F, AU - van Kempen,Loes, AU - de Vries,Henry J C, PY - 2018/2/22/pubmed PY - 2019/9/26/medline PY - 2018/2/22/entrez SP - 534 EP - 541 JF - Sexually transmitted diseases JO - Sex Transm Dis VL - 45 IS - 8 N2 - BACKGROUND: Victims could become infected with sexually transmitted infections (STIs) during a sexual assault. Several guidelines recommend presumptive antimicrobial therapy for sexual assault victims (SAVs). We assessed the STI positivity rate and treatment uptake of female and male SAVs at the Amsterdam STI clinic. METHODS: Sexual assault victims answered assault-related questions and were tested for bacterial STI (chlamydia, gonorrhea, and syphilis), hepatitis B, and HIV during their initial visits. Sexual assault victim characteristics were compared with non-SAV clients. Backward multivariable logistic regression analysis was conducted to assess whether being an SAV was associated with a bacterial STI. The proportion of those returning for treatment was calculated. RESULTS: From January 2005 to September 2016, 1066 (0.6%) of 168,915 and 135 (0.07%) of 196,184 consultations involved female and male SAVs, respectively. Among female SAVs, the STI positivity rate was 11.2% versus 11.6% among non-SAVs (P = 0.65). Among male SAVs, the STI positivity rate was 12.6% versus 17.7% among non-SAVs (P = 0.12). In multivariable analysis, female SAVs did not have increased odds for an STI (odds ratio 0.94; 95% confidence interval, 0.77-1.13), and male SAVs had significantly lower odds for an STI (odds ratio, 0.60; 95% confidence interval, 0.36-0.98). Of SAVs requiring treatment, 89.0% (female) and 92.0% (male) returned. CONCLUSIONS: The STI positivity rate among female SAVs was comparable with female non-SAVs, but male SAVs had lower odds for having a bacterial STI than did male non-SAVs, when adjusting for confounders. The return rate of SAV for treatment was high and therefore does not support the recommendations for presumptive therapy. SN - 1537-4521 UR - https://www.unboundmedicine.com/medline/citation/29465647/Sexually_Transmitted_Infection_Positivity_Rate_and_Treatment_Uptake_Among_Female_and_Male_Sexual_Assault_Victims_Attending_The_Amsterdam_STI_Clinic_Between_2005_and_2016_ L2 - https://doi.org/10.1097/OLQ.0000000000000794 DB - PRIME DP - Unbound Medicine ER -